Wearable health tech firm Neurovalens raises £6m in new funding

November 3, 2025

Neurovalens is a pioneering medical device company which specialises in leveraging the power of neuroscience and advanced technology to address a variety of global health challenges, including insomnia, anxiety and post-traumatic stress disorder (PTSD).

Today, the company has announced its £6m investment round, which we are proud to have participated in alongside  Investment Fund for Northern Ireland (managed by Clarendon Fund Managers), Whiterock ’s Growth Capital Fund, IQ Capital and Innovation Ulster Ltd.

The investment round will support Neurovalens’ commercial expansion across the US and global healthcare markets, advance its regulatory pipeline, and accelerate sales of its FDA-cleared devices.

Congratulations to Jason McKeown and the entire team. We look forward to supporting your next stage of growth.

Check out the full story in UKTN here: https://lnkd.in/gYguQG7e